Actively Recruiting
Evaluating DCog Short, an iPad-Based Tool for Early Neurotoxicity Detection in Patients Undergoing CAR-T Cell Therapy A Pilot Study
Led by Beth Israel Deaconess Medical Center · Updated on 2026-10-08
40
Participants Needed
1
Research Sites
48 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the effectiveness of DCog Short, a self-reporting iPad-based tool, in assessing neurotoxicity in participants undergoing CAR-T cell therapy for hematologic malignancies. This pilot study is the first to examine DCog Short for this purpose and involves participants at risk of treatment-associated neurotoxicity. The U.S. Food and Drug Administration has not approved DCog Short as a tool for neurotoxicity evaluation in this context. Participants will use DCog Short, which includes a series of cognitive tests delivered via iPad, to monitor neurotoxicity. During hospitalization, participants will have daily study visits, followed by phone visits twice weekly from days 14 to 21 and weekly from days 21 to 30 after CAR-T cell infusion. After hospital discharge, participants will keep the iPads for continued assessments until they return them at the 90-day follow-up visit. Participants will undergo screening for eligibility, complete questionnaires, and cognitive assessments using the DCog Short tool. The study tracks multiple measures such as sensitivity, specificity, and predictive values of DCog Short for early neurotoxicity detection up to 30 days after CAR-T infusion. Follow-up visits occur up to 90 days post-treatment to monitor neurotoxicity and cognitive changes. About 40 participants are expected to take part in the study, with assessments occurring both in person and via phone calls.
CONDITIONS
Brief Title
Assessing DCog Short for Neurotoxicity in CAR-T
Research Team
J
Jon Arnason, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here